Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.
Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan.American Journal of Hematology (impact factor: 4.67). 06/2011; 86(10):893. DOI:10.1002/ajh.22110 pp.893
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.